Clinical trial Recruiting at 9 sites Observational Ages 12 to 18

Dental discoloration and quality of life after early prolonged high bilirubin in children

Official title: Prevalence of Dental Dyschromia and Impact on the Quality of Life of Participants With Prolonged Hyperbilirubinemia During Their Early Years

Run by University Hospital, Toulouse · NCT06506734 · Data updated 2026-11-12

We will see if children with biliary atresia, PFIC, or Alagille syndrome who had prolonged high bilirubin as infants have more tooth discoloration and worse quality of life than those without discoloration.

More Dental Diseases trials

Quick facts

Study typeObservational
Ages12 Years to 18 Years
SexAll
Enrollment120 (estimated)
SponsorUniversity Hospital, Toulouse
Academic / other
Locations9 sites (Bordeaux and 8 other locations)
StatusRecruiting
StartedApril 7, 2026
Main results expectedOctober 7, 2027
Study endsOctober 7, 2027
Registry record updatedMay 12, 2026
Trial IDNCT06506734 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children with biliary atresia, progressive familial intrahepatic cholestasis (PFIC), or Alagille syndrome who experienced early prolonged hyperbilirubinemia and whose guardian can complete quality-of-life questionnaires are ideal candidates.

Probably not a fit

Patients who cannot understand or complete the questionnaires or whose tooth discoloration has a clear non-bilirubin cause are unlikely to benefit from the study findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will measure how common dental dyschromia is among children who experienced prolonged hyperbilirubinemia early in life and will collect information on bilirubin severity, duration, underlying liver disease, and treatments received. Participants or their legal representatives will complete questionnaires about dental appearance and quality of life, and dental examinations may be recorded when available. Data analysis will look for links between bilirubin exposure, specific diagnoses (biliary atresia, PFIC, Alagille syndrome), treatments, and the presence of tooth discoloration and its impact on quality of life. Findings will be used to inform clinical recommendations and discussions with insurers about coverage for dental care for affected children.

Why it matters

Potential benefit: If successful, this work could support coverage for dental care and targeted prevention or treatment for children who develop bilirubin-related tooth discoloration.

How similar studies have gone: Case reports and small series have linked neonatal hyperbilirubinemia to tooth discoloration, but few studies have quantified prevalence or measured quality-of-life impact, so the approach is only partially established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* A patient with biliary atresia, progressive familial intrahepatic cholestasis, or Alagille syndrome
* Patient or legal representative not opposed to participating in this research.

Exclusion Criteria:

* Inability to understand and respond to quality of life questionnaires

Where it's running

  • University Hospital Bordeaux
    Bordeaux, France
    Recruiting
  • University Hosptial Caen
    Caen, France
    Recruiting
  • University Hospital Lille
    Lille, France
    Recruiting
  • Hospices Civils de Lyon
    Lyon, France
    Recruiting
  • University Hospital Marseille
    Marseille, France
    Recruiting
  • Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, FHU Hépatinov
    Paris, France
    Recruiting
Show 3 more locations
  • Assistance Publique-Hôpitaux de Paris, Hôpital Bretonneau, Paris
    Paris, France
    Recruiting
  • Assistance Publique-Hôpitaux de Paris, Hôpital Necker
    Paris, France
    Recruiting
  • University Hospital Rennes
    Rennes, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.